A Patient‐to‐Model‐to‐Patient (PMP) Cancer Drug Discovery Protocol for Identifying and Validating Therapeutic Agents Targeting Tumor Regulatory Architecture

Laise, P., Bosker, G., Califano, A., & Alvarez, M. J. (2022). A Patient‐to‐Model‐to‐Patient (PMP) Cancer Drug Discovery Protocol for Identifying and Validating Therapeutic Agents Targeting Tumor Regulatory Architecture. Current Protocols, 2(9). Portico. https://doi.org/10.1002/cpz1.544
Authors:
Pasquale Laise
Gideon Bosker
Andrea Califano
Mariano J. Alvarez
Affiliated Authors:
Pasquale Laise
Andrea Califano
Mariano J. Alvarez
Columbia Affiliation:
Subjects:
Antineoplastic Agents (MeSH)
Neoplasms (MeSH)
Targeted Protein Degradation in Biomedical Research (OpenAlex Topic)
Genomic Landscape of Cancer and Mutational Signatures (OpenAlex Topic)
Analysis of Gene Interaction Networks (OpenAlex Topic)
Author Keywords:
biomarkers
cancer
drug discovery
regulatory networks
systems pharmacology
elink
Publication Type:
Article
Unique ID:
10.1002/cpz1.544
PMID:
36083100
DOI:
10.1002/cpz1.544
Journal:
Current Protocols
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: